|

PAS-004 Capsules Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Pasithea Therapeutics Corp.1

Indications

  • RAF Mutation1
  • NF1 Mutation1
  • RAS Mutation1
  • Advanced Solid Tumors1
  • Cancer1

Austin, Texas1 trial

PAS-004 in Patients With Advanced Solid Tumors

NEXT Oncology

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.